• Vaccine Name: ALVAC-BTV-VP2/VP5
• Target Pathogen: Bluetongue virus
• Target Disease: Bluetongue disesase
• Vaccine Ontology ID: VO_0004726
• Type: Recombinant vector vaccine
• Status: Research
• Host Species for Licensed Use: Baboon
• Vector:
  • Vector name:
  • VO vector ID: VO_0001128
• Preparation: A recombinant canarypox virus vector was used to co-express genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus (Boone et al., 2007).
• Immunization Route: Intramuscular injection (i.m.)

Sheep Response

• Vaccine Immune Response Type: VO_0000287
• Challenge Protocol: The field strain of BTV-17 was used for challenging (Boone et al., 2007).
• Efficacy: The sheep vaccinated with the recombinant canarypox virus vectored vaccine were resistant to challenge with a field strain of BTV-17 (Boone et al., 2007).